
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for 600624.SS and 80,000+ other tickers.
See exactly how 600624.SS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 600624.SS and 80,000+ other tickers.
Shanghai Fudan Forward S&T Co., Ltd maintains a diverse business portfolio encompassing software development, biopharmaceuticals, and property ventures. Its software division specializes in creating and exporting programs, notably to the Japanese market. Within its biopharmaceutical operations, the firm conducts comprehensive research, development, manufacturing, and distribution of a range of products, including chemical drugs, traditional Chinese medicines, freeze-dried powder injections, and various solid dosage forms. The company's real estate arm focuses on the conceptualization and…
No recent news available.